Isovalerylspiramycin I alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2 (NUBP2)-vascular non-inflammatory molecule-1 (VNN1) pathway

Update your browser to view ScienceDirect.

Request details:

Request ID: 8a5cd224ea0f942c-SJC
IP: 116.62.10.13
UTC time: 2024-07-19T18:37:06+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4